ErbB4

ErbB4 Overview

English NameReceptor protein-tyrosine kinase erbB-4Approved Drugs5
Drugs in Clinical Trials12Target SynonymEC 2.7.10,EC:2.7.10.1,ERBB4,Tyrosine kinase-type cell surface receptor HER4,s80HER4,p180erbB4,Receptor tyrosine-protein kinase erbB-4,4ICD,E4ICD,HER4,Erb-B2 Receptor Tyrosine Kinase 4,V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 4,Human Epidermal Growth Factor Receptor 4,Proto-Oncogene-Like Protein C-ErbB-4,V-Erb-A Avian Erythroblastic Leukemia Viral Oncogene Homolog-Like 4,Avian Erythroblastic Leukemia Viral (V-Erb-B2) Oncogene Homolog 4,V-Erb-A Erythroblastic Leukemia Viral Oncogene Homolog 4,ERBB4 Transcript Variant I12DEL,ERBB4 Transcript Variant I20DEL,EC 2.7.10.1,ALS19,Receptor, ErbB-4
Highest Development StageApproved
English NameReceptor protein-tyrosine kinase erbB-4
Target SynonymEC 2.7.10,EC:2.7.10.1,ERBB4,Tyrosine kinase-type cell surface receptor HER4,s80HER4,p180erbB4,Receptor tyrosine-protein kinase erbB-4,4ICD,E4ICD,HER4,Erb-B2 Receptor Tyrosine Kinase 4,V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 4,Human Epidermal Growth Factor Receptor 4,Proto-Oncogene-Like Protein C-ErbB-4,V-Erb-A Avian Erythroblastic Leukemia Viral Oncogene Homolog-Like 4,Avian Erythroblastic Leukemia Viral (V-Erb-B2) Oncogene Homolog 4,V-Erb-A Erythroblastic Leukemia Viral Oncogene Homolog 4,ERBB4 Transcript Variant I12DEL,ERBB4 Transcript Variant I20DEL,EC 2.7.10.1,ALS19,Receptor, ErbB-4
Approved Drugs5
Drugs in Clinical Trials12
Highest Development StageApproved

ErbB4 Product List

  • Product Category

    Protein (3)

  • Product Status

    Launched (3)

  • Species

    Human (3)

  • Tag

    His Tag (1)Fc Tag (1)His Tag & Avi Tag (1)

  • Conjugate

    Unconjugated (2)Biotin-labeled (1)

ErbB4 Background

Receptor tyrosine-protein kinase erbB-4 (ErbB4), also known as Her4, is a single-pass type I transmembrane glycoprotein that is a member of the ErbB family of tyrosine kinase receptors. ErbB family members serve as receptors for the epidermal growth factor (EGF) family of growth factors. ErbB4 is expressed in normal skeletal muscle, heart, pituitary, brain and several breast carcinomas. ERBB4 contains multiple furin-like cysteine rich domains, a tyrosine kinase domain, a phosphotidylinositol-3 kinase binding site and a PDZ domain binding motif. The protein binds to and is activated by neuregulins-2 and -3, heparin-binding EGF-like growth factor and betacellulin. Ligand binding induces a variety of cellular responses including mitogenesis and differentiation. Multiple proteolytic events allow for the release of a cytoplasmic fragment and an extracellular fragment. ErbB4 appears to play important roles in neuronal development, development of the heart and cancer. ERBB4 has been shown to interact with: DLG4, NRG1, STAT5A, and YAP1. Mutations in this gene have been associated with cancer. Other single-nucleotide polymorphisms and a risk haplotype have been linked to schizophrenia.

ErbB4 Synonyms

HER4,ErbB4,MGC138404,p180erbB4

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Recombinant human neuregulin-1rhNRG-1Phase 3 ClinicalZensun (Shanghai) Sci&Tech Co LtdHeart Failure; Heart Failure, Diastolic; Heart Failure, Systolic; Myocardial Infarction
Details
Larotinib MesylateZ-650Phase 3 ClinicalGuangdong Dongyangguang Pharmaceutical Co LtdEsophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Pancreatic Neoplasms; Solid tumours
Details
Allitinib TosylateAST-6; ALS-1306; AST-1306Phase 2 ClinicalShanghai Allist Pharmaceutical Technology Co LtdBreast Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
Varlitinib DitosylateSPS-4370; ASLAN-001; ARRY-334543; ARRY-543; QBT-01Phase 2 ClinicalArray BiopharmaBile Duct Neoplasms; Biliary Tract Neoplasms; Breast Neoplasms; Cholangiocarcinoma; Metastatic breast cancer; Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
Neratinib (Fukang (Shanghai) Health Technology)CVL009; CVL-009Phase 2 ClinicalConvalife (Shanghai) Co LtdCarcinoma, Non-Small-Cell Lung; Solid tumours; Uterine Neoplasms
Details
EO-1001NT-113; APL-122Phase 2 ClinicalEdison Pharmaceuticals IncNeoplasms
Details
JRF-103JRF103; JRF-103Phase 2 ClinicalShenzhen Jinrui Foundation Biotechnology Co LtdSolid tumours
Details
Pirotinib HydrochlorideKBP-5209Phase 2 ClinicalShandong Xuanzhu Pharmaceutical Technology Co LtdBreast Neoplasms; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Solid tumours
Details
PB-357PB-357Phase 1 ClinicalPfizer IncNeoplasms
Details
Sirotinib MaleateXZP-5491Phase 1 ClinicalShandong Xuanzhu Pharmaceutical Technology Co LtdCarcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Stomach Neoplasms
Details
XZP-5209XZP-5209Phase 1 ClinicalXuanzhu (Shijiazhuang) Biotechnology Co LtdCarcinoma, Non-Small-Cell Lung
Details
FCN-411FCN-411Phase 1 ClinicalCarcinoma, Non-Small-Cell Lung; Lung Neoplasms
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
Osimertinib MesylateAZD-9291; RDL94R2A16; AZD-9291 Mesylate; AZD9291ApprovedAstrazeneca Plc泰瑞沙, TagrissoUnited StatesCarcinoma, Non-Small-Cell LungAstrazeneca Pharmaceutical Co Ltd2015-11-13Adenocarcinoma; Adenocarcinoma of Lung; Brain metastases; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Colonic Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Glioblastoma; Glioma; Head and Neck Neoplasms; Hematologic Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphoma; Melanoma; Meningeal Neoplasms; Multiple Myeloma; Neoplasm, Residual; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Rectal Neoplasms; Skin Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Thyroid Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms
Details
Afatinib DimaleateBIBW-2992-MA2; BIBW-2992ApprovedC.H. Boehringer Sohn Ag & Co. KgGilotrif, Giotrif, Tovok, 吉泰瑞, TomtovokUnited StatesCarcinoma, Non-Small-Cell LungC.H. Boehringer Sohn Ag & Co. Kg2013-07-12Adenocarcinoma; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chordoma; Colorectal Neoplasms; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gallbladder Neoplasms; Gastroesophageal Junction Neoplasms; Glioblastoma; Glioma; Head and Neck Neoplasms; Hematologic Neoplasms; Liver Diseases; Lung Neoplasms; Lymphoma; Multiple Myeloma; Neoplasm Metastasis; Neoplasms; Neoplasms, Squamous Cell; Neuroectodermal Tumors; Penile Squamous Cell Carcinoma; Prostatic Neoplasms; Renal Insufficiency; Rhabdomyosarcoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Uterine Neoplasms
Details
Neratinib MaleateHKI-272; PF-0528767; WAY-179272; CAN-030; PB-272ApprovedPfizer IncNerlynx, 贺俪安, 汉奈佳, 赫赛佳, HerneraUnited StatesBreast NeoplasmsPuma Biotechnology Inc2017-07-17Brain metastases; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Glioblastoma; Hepatic Insufficiency; Lung Neoplasms; Metastatic breast cancer; Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Solid tumours; Stomach Neoplasms; Triple Negative Breast Neoplasms
Details
Pyrotinib MaleateBLTN; HTI-1001; SHR-1258ApprovedJiangsu Hengrui Medicine Co Ltd艾瑞妮Mainland ChinaBreast NeoplasmsJiangsu Hengrui Medicine Co Ltd2018-08-12Adenocarcinoma of Lung; Bile Duct Neoplasms; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Gastroesophageal Junction Neoplasms; Gastrointestinal Neoplasms; Lung Neoplasms; Metastatic breast cancer; Neoplasms; Solid tumours; Stomach Neoplasms
Details
DacomitinibPF-00299804-03; PF-00299804-3; PF-00299804; PF-299804; PF-299; PF-804ApprovedPfizer IncVizimproUnited StatesCarcinoma, Non-Small-Cell LungPfizer Inc2018-09-27Adenocarcinoma; Brain Neoplasms; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Colorectal Neoplasms; Esophageal Squamous Cell Carcinoma; Glioblastoma; Head and Neck Neoplasms; Liver Diseases; Lung Neoplasms; Mouth Neoplasms; Neoplasm Metastasis; Neoplasms; Penile Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms
Details
  • Overview
  • Product List
  • Marketed Drug Information
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland